Dale H. Conaway M.S. D.V.M.
Member of the Board of Directors
Member of the Scientific Advisory Board

Dr. Dale H. Conaway is currently the Deputy Regional Director and the Chief Veterinary Medical Officer for the Office of Research Compliance and Assurance (ORCA), a division of the United States Department of Health and Human Services in Atlanta, Georgia. From 1998 2001, he was the Manager of the Equine Drug Testing and Animal Disease Surveillance Labs for the Michigan Department of Agriculture.

From 1994-1998 he served as the Regulatory Affairs Manager for the Michigan Department of Public Health Vaccine Production Division. From 1988-1994 Dr. Conaway served as the Director of the Animal Facility at the Michigan Cancer Foundation (now a part of the Barbara Ann Karmanos Cancer Institute) as well as a Research Assistant Member. Research interests at the Cancer Foundation included, metastatic inhibition of malignant tumors, gene transfection in heterogeneous mammary tumor populations and immunocytochemical evaluation of lymphocyte populations within malignant tumors. Dr. Conaway studied surgical pathology at the College of Veterinary Medicine, Michigan State University (1982-1984), and was a Research Associate at the Department of Immunology, School of Medicine, Wayne State University in Detroit, MI (1985-1988). Dr. Conaway also did an internship in Veterinary Epidemiology, at Washington University School of Medicine in St. Louis, MO (1981-1982). Dr. Conaway received his Doctorate degree in Veterinary Medicine from Tuskegee University in 1979, and a Masters of Science degree from the College of Veterinary Medicine, at Michigan State University in 1984.

The following is a list of publications by Dr. Dale Conaway, selected from published peer-review articles and review papers.

Publications:

• Hodgin, E.C., Conaway, D.H., Ortenburger, A.I.: Recurrence of Nasal Coccidioidal Granuloma in a Horse. JAVMA , 184 (3) , 339-340, 1984
  
  
• Conaway, D. H., Padgett, G.A., Bunton, T.E., Nachreiner, R.F.: Clinical and Histological Features of Primary Progressive, Familial Thyroiditis in a Colony of Borzoi Dogs. Vet. Pathol., (220 439 446, 1985
  
  
• Conaway, D.H., Padgett, G.A., Nachreiner, R.F.: The Familial Occurrence of Lymphocytic Thyroiditis in Borzoi Dogs. American J. of Medical Genetics, (22) 409-424, 1985
  
  
• Conaway, D.H., Giraldo, A.A., David, C.S., Kong, Y.M. In Situ Kinetic Analysis of Thyroid Lymphocyte Infiltrates in Mice Developing Experimental Autoimmune Throiditis (EAT). Clin. Immunol. Immunopathol, 125:247-253, 1990.
  
  
• Conaway, D.H., Giraldo, AA., David, C.S., Kong, Y.M.: In Situ Analysis of T Cell Subset in Experimental Autoimmune Thyroiditis After Adoptive Transfer of Activated Spleen Cells. Cellular Immunology, 125:247-253, 1990.
  
  
• Flynn, J.C., Conaway, D.H., Cobbold S., Waldmann, H. Kong, Y.M.: Depletion of L3T4+ and Lyt-2+ Cells by Rat Monoclonal Antibodies Alters the Development of Adoptively Transferred Experimental Autoimmune Thyroiditis. Cellular Immunology, 122:377-390, 1989
  
  
• Welch, D.R., Bisi, J.E., Miller, B.E., Conaway, D.H., Seftor, E.A., Yohem, K.H.,Gilmore, L.B., Seftor, R.E.B., nakajama, M. and Hendrix, M.J.C. Characterization of a Highly Aggressive Human Melanoma Cell Line In vivo and In-vitro: Invasive and Metastatic Properties. Intl. J. of Cancer, 47:227-237, 1991
  
  
• Aslakson, C.J., McEachern, D., Conaway, D.H., Miller, F.R.: Inhibition of Lung Colonization at Two Different Steps in the Metastatic Sequence. Clin. And Exp. Metastasis, 9:139-150, 1991
  
  
• Hendrix, M.J.C., Seftor, E.A., Chu, Y.W., Seftor, R.E., Nagle, R.B., McDaniel, K.M., Leong, S.P., Yohem, K.H., Leibowitz, a.M., Meykens, F.L., Conaway d.H., et.al. Coexpression of Vimentin and Cytokeratins by Human Menanoma Tumor Cells: Correlation with Invasive and Metastatic Potential. JNCI, 84:165-174, 1992
  
  
• Conaway, D.H. Diagnostic Exercise: Abcessation in Castrated Outbred Immunodeficient (CD-1) Mice.
  
  
• Fidel, P.I., Lynch, M.E., Conaway, D.H., et.al. Mice Immunized by Primary Vaginal Candida Albicans Infection Develop Acquired Mucosal Immunity: 63:547-553, 1995

Presentations and Meetings:

• Conaway, D.H.: Progressive Familial Thyroiditis in a Colony of Borzoi Dogs, presented at Wayne State University at the Immunological Seminar in Detroit, MI, 1984.
  
  
• Conaway, D.H. et al.: In situ Analysis of Thyroid T Cell Infiltrates in Murine Experimental Autoimmune Thyroiditis (EAT). April, 1987. Federation of American Societies for Experimental Biology (FASEB) Symposium. Washington D.C.
  
  
• Flynn, Conaway, D.H. et al.: Altered Development of Adoptively Transferred Experimental Autoimmune Thyroiditis (EAT) by Rat Monoclonal Antibodies (mAbs) to L3T4 and Lyt-2Antigens. Midwest Autumn Immunology conference, November 1987, Chicago, IL.
  
  
• American Association of Immunologists (AAI) Course in Advanced Immunology. "Regulatory Mechanisms in Immunity." Lindenwood College, St. Charles, MO. June 1-8, 1986
  
  
• Flynn, Conaway et al.: Altered Development of Adoptively Transferred EAT by Rat mAb to L3T4 and Lyt-2 antigens. FASEB Symposium. Las Vegas, Nevada. 1988.
  
  
• Conaway, D.H.: "the Immunologic Kinetics of Autoimmune Thyroiditis." Presented at the National Cancer Institute, NIH: Bethesda, MD. March, 1988.
  
  
• American Association for Cancer Research (AACR) 80^th Annual Meeting. May 24-27, 1989, San Francisco, CA.
  
  
• Pathology of Laboratory Animals AFIP. Bethesda, MD. August 12-16, 1991
  
  
• Conaway, D.H.: Immunopathologic and Histopathologic Characterization of a Human Melanoma Cell Line. Seminar Presentation of St.Louis University, St. Louis, MO. Mrch 6, 1992
  
  
• Techniques and Interpretation for Immunohistochemistry, Thomas Jefferson University, Philadelphia, PA.
  
  
• 43^rd Annual AALAS (American Association for Lab Animal Sciences) San Diego, CA
  
  
• 83^rd Annual AACR Orlando, Fl. 1992
  
  
• MMS.1 Compound As a Potential Therapy In HIV Infected Individuals. NIH, NAIDS, Bethesda, MD. May 12, 1994. Presentation
  
  
• Biologics Approval Workshop: Regulatory Affairs Professional Society. Washington, D.C. Oct. 19-21, 1994
  
  
• "Regulatory Compliance" Workshop presented by the Center for Professional Advancement, N.J. Nov. 30-Dec. 1, 1994
  
  
• "Contemporary Drug Technology" Workshop presented by the Center for Professional Advancement, East Brunswick, N.J. August 7-10, 1995
  
  
• Increased Survival with Improved Immune Function in LP-BM5 MuLV Murine Immunodeficiency Disease (MAIDS) with Multiple Mitogenic Stimulator (MMS-1) Poster presentation at: "Immunopatheogenesis of HIV" Conference. Hilton Head, S.C. March 26, 1996
  
  
• Regulatory Approval and Compliance Workshop: May 20-22, 1997. Waltam, Mass.
  
  
• 23rd Biennial State Public Health Vector Control Conference: Arbo Virus Transmission: January 30-February 1, 2000. Sponsored by the CDC, Fort Collins, CO